GlassScriptPhysician profile
Brain A Dolsey
NPI 1508984956
$3,878.85
in general payments reported to CMS, 2019-2025
26 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $270 · 2021: $238 · 2022: $578 · 2023: $309 · 2024: $1,000 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064 · Travel and Lodging: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.50 |
| Travel and Lodging | $426.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,515.76 | 2019-2023 | Ultreon |
| Shockwave Medical, INC | $636.10 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $243.75 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $217.55 | 2020-2025 | Farxiga, Wainua |
| Abiomed | $155.01 | 2022-2024 | Impella |
| Cardiovascular Systems INC. | $147.42 | 2019-2020 | |
| Boston Scientific Corporation | $121.00 | 2020 | |
| Biotronik INC. | $90.95 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.76 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.78 | 2021-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $74.29 | 2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $65.84 | 2019-2022 | |
| Terumo Medical Corporation | $59.32 | 2022-2023 | Metacross Otw, Angio-Seal, Glidewire |
| Novartis Pharmaceuticals Corporation | $53.22 | 2024-2025 | |
| Amgen INC. | $51.19 | 2021-2024 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $49.65 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $44.85 | 2024 | Barostim Neo System |
| Philips North America LLC | $43.79 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $27.00 | 2021-2022 | |
| Esperion Therapeutics, INC. | $22.55 | 2025 | Nexletol |
| Medtronic, INC. | $20.83 | 2023 | Onyx Frontier |
| Inspire Medical Systems, INC. | $17.64 | 2024 | Inspire |
| Amarin Pharma, INC. | $15.36 | 2021 | |
| Merck Sharp & Dohme LLC | $14.60 | 2025 | Verquvo |
| Pfizer INC. | $13.55 | 2025 | |
| Cardinal Health 200 LLC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brain Dolsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.